BLUE — bluebird bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for bluebird bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,385	1,106	1,151	300	180
Net Total Accounts Receivable
Net Total Receivables	0.019	0.4	0.4	—	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,419	1,152	1,216	337	199
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	247	337	347	101	291
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,243	1,727	1,781	594	555
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	146	224	204	153	128
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	358	442	426	220	359
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,885	1,285	1,355	374	196
Total Liabilities & Shareholders' Equity	2,243	1,727	1,781	594	555
Total Common Shares Outstanding